Insider Transactions in Q1 2025 at Acelrx Pharmaceuticals Inc (ACRX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2025
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,644
-8.92%
|
$0
$0.67 P/Share
|
|
Feb 14
2025
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
10,575
-5.26%
|
$0
$0.67 P/Share
|
|
Feb 14
2025
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,245
-9.15%
|
$0
$0.67 P/Share
|
|
Feb 11
2025
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,060
-2.9%
|
$0
$0.62 P/Share
|
|
Feb 11
2025
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
880
-2.88%
|
$0
$0.62 P/Share
|
|
Feb 11
2025
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,517
-1.72%
|
$0
$0.62 P/Share
|
|
Feb 10
2025
|
Raffi Asadorian Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,059
-2.82%
|
$0
$0.63 P/Share
|
|
Feb 10
2025
|
Badri N Dasu Chief Engineering Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
879
-2.8%
|
$0
$0.63 P/Share
|
|
Feb 10
2025
|
Vincent J. Angotti CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,515
-1.69%
|
$0
$0.63 P/Share
|